Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2017 08:30 ET | Source: Cytori Therapeutics

Cytori Provides Latest Corporate Update at the 18th Annual B. Riley & Co. Institutional Investor Conference

SAN DIEGO, May 16, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that it will present at the 18th Annual B. Riley & Co. Institutional Investor Conference...
May 11, 2017 16:25 ET | Source: Cytori Therapeutics

Cytori Reports First Quarter 2017 Business and Financial Results

SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ:CYTX) (“Cytori” or the “Company”) today announced its first quarter 2017 financial results and provided updates on its...
May 10, 2017 09:00 ET | Source: Cytori Therapeutics

One Year Follow Up of Cytori Cell Therapy™ in Investigator Erectile Dysfunction Trial

SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announces one year follow up data of ADRCs (Cytori Cell Therapy™) treatment in post prostatectomy...
May 05, 2017 19:00 ET | Source: Cytori Therapeutics

Cytori Therapeutics Announces Inducement Grants for New Employees

SAN DIEGO, May 05, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) (the “Company”), announced today that the Compensation Committee of the Company's Board of Directors granted...
April 27, 2017 16:30 ET | Source: Cytori Therapeutics

Cytori to Webcast First Quarter Financial Results on May 11

SAN DIEGO, April 27, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) will provide a live webcast of its first quarter financial results and business update on Thursday, May 11, 2017...
April 11, 2017 08:45 ET | Source: Cytori Therapeutics

Cytori Announces Pricing of $9.5M Public Offering of Common Stock

SAN DIEGO, April 11, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (“Cytori” or the “Company”) (NASDAQ:CYTX) announced today that it has priced an underwritten public offering of 8,600,000...
April 10, 2017 16:01 ET | Source: Cytori Therapeutics

Cytori Announces Proposed Public Offering of Common Stock

SAN DIEGO, April 10, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (“Cytori” or the “Company”) (NASDAQ:CYTX) announced today that it intends to offer and sell shares of its common stock in an...
April 10, 2017 07:00 ET | Source: Cytori Therapeutics

Cytori Receives U.S. FDA Approval for Burn Clinical Trial Related to BARDA Contract

SAN DIEGO, April 10, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device...
April 03, 2017 07:00 ET | Source: Cytori Therapeutics

Cytori Appoints Gregg Lapointe to Board of Directors

SAN DIEGO, April 03, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) (“Cytori” or the “Company”) today announced that Gregg Lapointe has joined the Company’s Board of...
March 23, 2017 16:25 ET | Source: Cytori Therapeutics

Cytori Reports Fourth Quarter and Full Year 2016 Business and Financial Results

SAN DIEGO, March 23, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ:CYTX) (“Cytori” or the “Company”) today announced its fourth quarter and year-end 2016 financial results and provided...